Further research of the signaling pathways that regulate 4E-BP1 phosphorylation in Xp11.2 RCC may reveal additional therapeutic strategies to attenuate unrestricted protein biosynthesis in this cancer. Here, EIF4EBP1 is linked to renal cell carcinoma.